Federal award
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
SPE2DP26P0327
Contract
Obligated and Ceiling
- Obligated (net)
- $148,770.00
- Ceiling (potential value, not spending)
- $148,770.00
- Current value
- $148,770.00
- Gross positive obligations
- $148,770.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- AMNEAL PHARMACEUTICALS OF NEW YORK, LLC · LVEBAQTPN615
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- AMNEAL PHARMACEUTICALS OF NEW YORK, LLC · LVEBAQTPN615
- Awarding agency
- Department of War · sub-agency 97AS · office SPE2DP
- Funding agency
- Department of War · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325411 · MEDICINAL AND BOTANICAL MANUFACTURING
- PIID
- SPE2DP26P0327
- Award type code
- B
- Actions
- 1 · Feb 11, 2026 to Feb 11, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History1
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Feb 11, 2026 | FY2026 | 0 | — | $148,770.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.